Related Experiment Video
Updated: Sep 3, 2025

05:24
Author Spotlight: Exploring Plasticity of Sympathetic Neurons
Published on: July 5, 2024
2.6K
Human lumbar sympathetic blockade: An anatomical study to address potential block failure
Maite Bovaira1, Carles García-Vitoria1, Ana Carrera2
1Anesthesia Department, Hospital Intermutual de Levante, Sant Antoni de Benaixeve, Valencia, Spain.
Summary
Lumbar sympathetic blocks for chronic pain have a high failure rate. This study found anatomical variations explain failures, leading to a refined technique targeting the L4 vertebra for improved success.
Area of Science:
- Anatomy
- Pain Management
- Interventional Radiology
Background:
- Lumbar sympathetic blocks are a common treatment for complex regional pain syndrome.
- High failure rates suggest a need to optimize the procedure.
Purpose of the Study:
- To investigate anatomical variations influencing lumbar sympathetic block success.
- To refine the lumbar sympathetic block technique based on anatomical findings.
Main Methods:
- Simulated lumbar sympathetic trunk blocks performed on unembalmed human cadavers (n=4).
- Injections at L2 and L4 vertebral body levels under fluoroscopic guidance, followed by dye injection and dissection.
- Comparison of dye spread with fluoroscopic contrast medium distribution.
Main Results:
- Significant anatomical variations in sympathetic ganglia location were observed across vertebral levels and individuals.
- Dye spread patterns highlighted potential inaccuracies in targeting with traditional methods.
- The L4 vertebral level demonstrated a more consistent anatomical target.
Conclusions:
- Anatomical variability is a key factor in lumbar sympathetic block failure.
- A refined technique using an extraforaminal approach at the L4 vertebral level is recommended.
- This optimized approach aims to improve the efficacy of lumbar sympathetic blocks for pain management.
Related Concept Videos
Local Anesthetics: Clinical Application as Spinal Anesthesia
745
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
745
Sympathetic Pathways: Sympathetic Chain Ganglia
3.4K
The sympathetic chain ganglia, also known as the sympathetic trunk ganglia or paravertebral ganglia, are a series of ganglia located bilaterally on either side of the spinal column. These ganglia serve as relay stations for the sympathetic nervous system. Preganglionic neurons originating in the spinal cord project their axons to the sympathetic chain ganglia. Within the ganglia, these preganglionic fibers synapse with postganglionic neurons.The postganglionic neurons of the sympathetic trunk...
3.4K
Sympathetic Division of the ANS
2.1K
The sympathetic division of the autonomic nervous system (ANS) plays a crucial role in preparing the body for stress, physical activity, and increased energy demands. This division activates the "fight-or-flight" response, enabling individuals to respond effectively to challenging situations.
Originating in the thoracic and lumbar spinal cord segments, the preganglionic fibers of the sympathetic division exit the spinal cord through the white ramus communicans. They then enter the...
Originating in the thoracic and lumbar spinal cord segments, the preganglionic fibers of the sympathetic division exit the spinal cord through the white ramus communicans. They then enter the...
2.1K
Drugs Acting on Autonomic Ganglia: Blockers
1.1K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.1K

